Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia

BACKGROUND: Waldenstrom's Macroglobulinemia (WM) is a rare low-grade lymphoproliferative disorder. Based on preclinical studies, we conducted a phase II clinical trial testing the efficacy and safety of the Akt inhibitor perifosine in patients with relapsed/refractory WM. PATIENTS AND METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ghobrial, Irene M., Roccaro, Aldo, Hong, Fangxin, Weller, Edie, Rubin, Nancy, Leduc, Renee, Rourke, Meghan, Chuma, Stacey, Sacco, Antonio, Jia, Xiaoying, Azab, Feda, Azab, Abdel Kareem, Rodig, Scott, Warren, Diane, Harris, Brianna, Varticovski, Lyuba, Sportelli, Peter, Leleu, Xavier, Anderson, Kenneth C., Richardson, Paul G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2885252/
https://ncbi.nlm.nih.gov/pubmed/20103671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1837
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky